Location History:
- St. Petersburg, RU (2018)
- Slapanice, CZ (2022 - 2023)
Company Filing History:
Years Active: 2018-2023
Title: Fedor Nikulenkov: Innovator in Nuclease Inhibition
Introduction
Fedor Nikulenkov is a prominent inventor based in St. Petersburg, Russia. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit nucleases. With a total of three patents to his name, his work is crucial in addressing various health challenges.
Latest Patents
Nikulenkov's latest patents include innovative compounds that serve as inhibitors of nucleases. The first patent describes substituted aminothiazoles, which are represented by a specific structural formula. These compounds are particularly useful in the treatment and prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability-associated diseases. The second patent focuses on substituted propanamides, which also act as inhibitors of nucleases and share similar applications in medical treatment.
Career Highlights
Fedor Nikulenkov is affiliated with Masarykova Univerzita, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential impact on therapeutic methods and disease prevention.
Collaborations
Nikulenkov collaborates with notable colleagues, including Kamil Paruch and Benoit Carbain. Their combined expertise enhances the research and development of effective nucleases inhibitors.
Conclusion
Fedor Nikulenkov's contributions to the field of biochemistry through his innovative patents highlight his role as a key inventor in the fight against various diseases. His work continues to pave the way for advancements in medical treatments.